During the past decade, Atlanta Gastroenterology Associates conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Atlanta Gastroenterology Associates" are "Colonic Diseases" (2 trials), "Colorectal Cancer" (2 trials), "Colorectal Neoplasms" (2 trials), "Diabetic Gastroparesis" (2 trials) and "Digestive System Diseases" (2 trials). Many other conditions were trialed in "Atlanta Gastroenterology Associates" in a lesser frequency.

Most popular intervention types in "Atlanta Gastroenterology Associates" are "Drug" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Metoclopramide Nasal Spray" (2 trials), "Placebo" (2 trials), "Placebo Nasal Spray" (2 trials), "Golimumab" (1 trials) and "Guselkumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Atlanta Gastroenterology Associates" are 5 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Atlanta Gastroenterology Associates". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Atlanta Gastroenterology Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Atlanta Gastroenterology Associates, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".